Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rxo (RXO) EPS (Basic) (2021 - 2025)

Historic EPS (Basic) for Rxo (RXO) over the last 5 years, with Q4 2025 value amounting to -$0.27.

  • Rxo's EPS (Basic) fell 125000.0% to -$0.27 in Q4 2025 from the same period last year, while for Dec 2025 it was -$0.58, marking a year-over-year increase of 7128.71%. This contributed to the annual value of -$0.59 for FY2025, which is 7281.11% up from last year.
  • Rxo's EPS (Basic) amounted to -$0.27 in Q4 2025, which was down 125000.0% from -$0.08 recorded in Q3 2025.
  • In the past 5 years, Rxo's EPS (Basic) registered a high of $0.38 during Q2 2022, and its lowest value of -$1.81 during Q3 2024.
  • Over the past 5 years, Rxo's median EPS (Basic) value was -$0.02 (recorded in 2024), while the average stood at -$0.07.
  • As far as peak fluctuations go, Rxo's EPS (Basic) soared by 13333.33% in 2023, and later plummeted by 1800000.0% in 2024.
  • Rxo's EPS (Basic) (Quarter) stood at $0.36 in 2021, then crashed by 108.33% to -$0.03 in 2022, then surged by 133.33% to $0.01 in 2023, then tumbled by 300.0% to -$0.02 in 2024, then tumbled by 1250.0% to -$0.27 in 2025.
  • Its EPS (Basic) stands at -$0.27 for Q4 2025, versus -$0.08 for Q3 2025 and -$0.05 for Q2 2025.